Wood J H, Thakker K M
Eur J Clin Pharmacol. 1982;23(2):183-8. doi: 10.1007/BF00545976.
It is shown that the absorption of phenylbutazone, naproxen, and chlorthiazide is governed by a dose limiting mechanism. This dose dependency may be explained by a saturation absorption process mathematically obeying Michaelis-Menten type kinetics. Observed dose relationships for tetracycline, fenclozic acid and related compounds, phenytoin, and possibly digoxin and digitoxin may be explained if a saturable process in absorption is postulated. This behavior may be produced by insolubility of the drug compound, a limited "window of absorption" in the gastrointestinal tract, or a capacity limited absorption because of the carrier or the transport mechanism involved. The need for suitably designed dose response studies with new drug compounds is discussed.
结果表明,保泰松、萘普生和氯噻嗪的吸收受剂量限制机制的控制。这种剂量依赖性可以用数学上符合米氏动力学的饱和吸收过程来解释。如果假定吸收过程中存在饱和过程,则可以解释四环素、氯苯氧酸及相关化合物、苯妥英钠,可能还有地高辛和洋地黄毒苷的观察到的剂量关系。这种行为可能是由于药物化合物的不溶性、胃肠道中有限的“吸收窗口”,或者是由于所涉及的载体或转运机制导致的容量限制吸收。文中讨论了对新药物化合物进行适当设计的剂量反应研究的必要性。